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Analyses of microbial genome sequences have revealed numerous examples of ‘cryptic’ or
‘orphan’ biosynthetic gene clusters, with the potential to direct the production of novel, structurally
complex natural products. This article summarizes the various methods that have been developed
for discovering the products of cryptic biosynthetic gene clusters in microbes and gives an
account of my group’s discovery of the products of two such gene clusters in the model
actinomycete Streptomyces coelicolor M145. These discoveries hint at new mechanisms, roles
and specificities for natural product biosynthetic enzymes. Our efforts to elucidate these are
described. The identification of new secondary metabolites of S. coelicolor raises the question:
what is their biological function? Progress towards answering this question is also summarized.
Introduction
Alexander Fleming’s discovery of penicillin in 1928 and its
subsequent development into a medicine by Florey and
Chain in the 1940s provided the foundation for devel-
opment of microbial natural products as a cornerstone of
new drug discovery in the 20th century (Fleming, 1929;
Chain et al., 1940). By the end of the century many
microbial natural products had found their way into the
clinic as antibacterial, antifungal, antiparasitic, anticancer
and immunosuppressive agents. Yet the turn of the century
also witnessed a mass withdrawal of large pharmaceutical
companies from new microbial natural product discovery
and microbial natural products research (Koehn & Carter,
2005). Several factors spurred this retreat, including
rediscovery of known natural products with high fre-
quency, the technical challenges associated with purifica-
tion and structure elucidation of natural products from
microbial fermentations and the advent of combinatorial
chemistry, which promised to provide a wealth of new
compounds to screen for biological activity. At the very
time natural product discovery programmes were ramping
down in the late 1990s, large-scale microbial genome
sequencing began to ramp up, fuelled by the pioneering
application of whole-genome shotgun sequencing to
Haemophilus influenzae, published in 1995, which demon-
strated that microbial genome sequences could be obtained
with hitherto unimagined rapidity (Fleischmann et al.,
1995). At present there are more than 580 complete
microbial genome sequences. Dramatic and sustained
increases in our understanding of the genetics and
enzymology of microbial natural product biosynthesis
throughout the 1990s have also facilitated the identification
and analysis of gene clusters likely to encode natural
product biosynthetic pathways in sequenced microbial
genomes (Fischbach & Walsh, 2006).
It was extremely fortunate that the Wellcome Trust funded
me to carry out research as a postdoctoral fellow in the
Department of Genetics at the John Innes Centre in 2000–
2001, just as the Streptomyces coelicolor A3(2) genome
sequencing project was nearing completion. S. coelicolor
was one of the first sequenced microbes in which it was
recognized that there are many more gene clusters
encoding natural product-like biosynthetic pathways than
there are known natural products of the organism (Bentley
et al., 2002). Similar observations have now been reported
for several diverse sequenced micro-organisms (Bok et al.,
2006; Ikeda et al., 2003; Keller et al., 2005; Oliynyk et al.,
2007; Omura et al., 2001; Paulsen et al., 2005; Udwary
et al., 2007). This discovery provided a strong counter-
argument to the idea that few novel compounds remain to
be discovered from natural sources and suggested that the
withdrawal of big pharmaceutical companies from natural
product drug discovery was premature. At the inception of
my independent academic career, we set out to investigate
the so-called ‘cryptic’ or ‘orphan’ natural product biosyn-
thetic gene clusters found within the genomes of S.
coelicolor and other sequenced microbes that encode
natural product biosynthesis-like proteins not associated
with the production of known metabolites. Over the past 6
years numerous groups around the world have focused on
similar objectives and today ‘genome mining’ for new
natural products and biosynthetic pathways has become a
dynamic and rapidly advancing field (Corre & Challis,
2007; Challis, 2008; Gross, 2007; Wilkinson & Micklefield,
2007).
Abbreviations: A, adenylation; ACP, acyl carrier protein; CDA, calcium-
dependent antibiotic; FAS, fatty acid synthase; fhOrn, N5-formyl-N5-
hydroxyornithine; hOrn, N5-hydroxyornithine; NRPS, nonribosomal pep-
tide synthetase; PCP, peptidyl carrier protein; PKS, polyketide synthase;
TE, thioesterase.
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In the first part of this article I will briefly review the
different approaches various groups have taken for
discovering the metabolic products of cryptic natural
product biosynthetic gene clusters. An account of our
discovery of new metabolites of S. coelicolor follows,
along with a discussion of the investigations by us and
others of the biosynthesis and biological functions of these
metabolites.
Strategies for identifying the metabolic products
of cryptic gene clusters
Many microbial natural products, in particular complex
polyketides and nonribosomal peptides, are assembled by
biosynthetic assembly lines involving modular mega-
synthases and synthetases (Fischbach & Walsh, 2006). In
many cases the number of modules in the assembly line
corresponds exactly to the number of metabolic building
blocks incorporated into the final product, although several
exceptions to this paradigm have emerged in recent years
(Haynes & Challis 2007). The presence or absence of
domains with ‘tailoring’ activities in individual modules
often allows prediction of the way in which an initially
selected metabolic building block gets modified during the
process of its incorporation into the natural product
(Fischbach & Walsh, 2006). Models that predict the
stereochemical outcome of some of these tailoring reac-
tions, e.g. ketoreduction, have also emerged recently
(Caffrey, 2003; Reid et al., 2003). Models that predict the
substrate specificity of the adenylation (A) and acyltrans-
ferase (AT) domains responsible for building block
selection in each module of nonribosomal peptide
synthetase (NRPS) and polyketide synthase (PKS) assembly
lines have also been reported and continue to be developed
(Haydock et al., 1995; Banskota et al., 2006a, b; Stachelhaus
et al., 1999; Challis et al., 2000; Rausch et al., 2005). Insight
into the structural features of the metabolic products of
cryptic biosynthetic assembly lines can often be derived by
application of the above bioinformatics analyses (Banskota
et al., 2006a, b; Bentley et al., 2002; Challis & Ravel, 2000;
Chen et al., 2007; de Bruijn et al., 2007; McAlpine et al.,
2005; Minowa et al., 2007; Nguyen et al., 2008; Paulsen
et al., 2005; Sudek et al., 2006; Tohyama et al., 2004; Udwary
et al., 2007; Zirkle et al., 2004). Such structural insights can
lead to the prediction of putative physico-chemical
properties of a metabolic product of a cryptic biosynthetic
system. The search of fermentation broths for products of
cryptic pathways can be narrowed to target only metabolites
with the predicted physico-chemical properties, thus
simplifying the analytical challenge (Fig.1). Several new
metabolic products of cryptic biosynthetic gene clusters have
been discovered using such methodologies (Lautru et al.,
2005; McAlpine et al., 2005; Banskota et al., 2006a, b).
Two other approaches that have been applied to cryptic
biosynthetic systems where the substrates of enzymes in the
pathways can be predicted are the ‘genomisotopic
approach’ and in vitro reconstitution. In the genomisotopic
approach, stable-isotope-labelled putative precursors of the
metabolic product are fed to the organism containing the
cryptic biosynthetic gene cluster and 2D NMR experiments
are used to screen extracts of the fermentation broth to
identify metabolites containing the labelled precursors
(Fig. 2; Gross et al., 2007). NMR detection of the labelled
metabolites can be used to guide fractionation of the
extracts to facilitate their purification. This approach
has been applied to isolation of the orfamides, novel
macrocyclic lipopeptides predicted to be produced by
Pseudomonas fluorescens Pf-5 from analysis of its genome
Fig. 1. Method for identifying the product(s) of cryptic biosyn-
thetic gene clusters by predicting likely physico-chemical prop-
erties of the product from sequence analyses.
Fig. 2. Principles of the genomisotopic approach for identifying
the product(s) of cryptic biosynthetic gene clusters.
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sequence (Gross et al., 2007). In the in vitro reconstitution
approach, the predicted substrates of a biosynthetic
enzyme, which has been produced in pure recombinant
form, are incubated with it and the structures of the
products are determined (Fig. 3). Epi-isozizaene is an
example of a new compound that has been identified as the
product of a cryptic sesquiterpene synthase discovered by
the S. coelicolor genome sequencing project using the in
vitro reconstitution approach (Lin et al., 2006). This
metabolite has recently been shown to be an intermediate
in the assembly of the known Streptomyces sesquiterpene
albaflavenone (Zhao et al., 2008).
For some types of biosynthetic system, substrate specificity
cannot be predicted with any degree of confidence from
bioinformatics analyses. In these cases the directed
approaches described above are not useful for finding the
metabolic products of cryptic biosynthetic pathways and
more generic approaches are required. Two related more
generic approaches that have been used successfully to
discover the products of cryptic biosynthetic gene clusters
are gene knockout/comparative metabolic profiling and
heterologous gene expression/comparative metabolic pro-
filing (Corre & Challis, 2007). The first of these involves
inactivation of a gene within the cryptic biosynthetic gene
cluster hypothesized to be essential for metabolite biosyn-
thesis, followed by comparison of the metabolites in the
culture supernatants or extracts of the wild-type organism
and the non-producing mutant using an appropriate
analytical technique such as liquid chromatography-mass
spectrometry (LC-MS). Metabolites present in the wild-
type but lacking in the mutant are likely products of the
cryptic gene cluster (Fig. 4), which can be isolated and
structurally characterized. Germicidins are an example of
metabolites discovered using this strategy (Song et al.,
2006). In the second approach the entire biosynthetic gene
cluster is cloned, often in a single cosmid or BAC vector,
and expressed in a heterologous host. The profile of
metabolites in culture supernatants or extracts of the
heterologous host containing and lacking the cloned
cryptic biosynthetic gene cluster are compared using LC-
MS or other appropriate analytical techniques. Metabolites
present in the host containing the gene cluster, but absent
in the host lacking the cluster, are likely products of the
cryptic biosynthetic pathway (Fig. 5), which can be purified
and structurally characterized as in the first approach.
CBS40 is an example of a novel metabolite that has been
identified by this approach (Hornung et al., 2007). One
potential obstacle which often has to be overcome in the
Fig. 3. The in vitro reconstitution approach for identifying the
product(s) of cryptic biosynthetic gene clusters. The structure(s) of
the product(s) resulting from incubation of the predicted sub-
strate(s) with the purified enzyme are determined.
Fig. 4. The gene knockout/comparative metabolic profiling
approach to identifying the product(s) of cryptic biosynthetic gene
clusters.
Fig. 5. The heterologous expression/comparative metabolic pro-
filing approach to identifying the product(s) of cryptic biosynthetic
gene clusters.
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heterologous expression/comparative metabolic profiling
approach is that natural product biosynthetic gene clusters
are often large (.40 kb) and therefore it can be difficult to
clone the entire cluster in a single vector. The use of
multiple, mutually compatible expression vectors is one
approach to overcoming this problem (Challis, 2006),
although it has yet to be applied to the discovery of new
metabolic products of cryptic biosynthetic gene clusters.
In the majority of the above approaches a common
problem can be encountered: that the cryptic biosynthetic
gene cluster is not expressed in the wild-type organism or
heterologous host in laboratory culture. The exception is
the in vitro reconstitution approach, which removes the
biosynthetic genes from their natural regulatory context by
expressing them under the control of a heterologous (and
usually inducible) promoter. However, the in vitro
reconstitution of an entire biosynthetic pathway usually
involves separate overexpression of each gene and puri-
fication of the resulting overproduced protein, and many
cryptic gene clusters contain multiple putative biosynthetic
genes. Thus, the discovery of a fully elaborated metabolic
product by this approach is likely to be very laborious. Two
approaches to address this problem in Aspergillus nidulans
have been reported (Bok et al., 2006; Bergmann et al.,
2007). The first involved comparative profiling of gene
expression in cryptic biosynthetic clusters in the wild-type,
and mutants with the pleiotropic regulator of secondary
metabolism laeA either deleted or overexpressed (Bok et al.,
2006). Gene clusters that are differentially expressed in the
mutants compared with the wild-type are identified as
putatively involved in secondary metabolic biosynthesis.
This approach offers potential for the discovery of new
metabolic products of cryptic biosynthetic pathways
because overexpression of laeA causes increased expression
of some Aspergillus cryptic gene clusters. However, this
potential has yet to be demonstrated by the discovery of a
novel Aspergillus natural product. The second approach
involves expression of putative pathway-specific activator
genes from within silent cryptic biosynthetic gene clusters
under the control of an inducible promoter (Bergmann
et al., 2007). This approach has been shown to cause
expression of a normally silent gene cluster in A. nidulans
upon addition of the inducer. Aspyridones, the metabolic
products of this gene cluster, were identified by compar-
ative metabolic profiling of the wild-type and mutant
strains and spectroscopic analyses showed them to have
novel structures, thus proving the utility of this approach
for discovering new natural products of cryptic biosyn-
thetic gene clusters that are not expressed in laboratory
cultures (Bergmann et al., 2007; Fig. 6).
The various strategies summarized above for identifying
the metabolic products of cryptic biosynthetic gene clusters
have different strengths and weaknesses, depending on how
much can be deduced about the structure of the products
from bioinformatics analyses, the size of the gene cluster,
and whether the gene cluster is well expressed in laboratory
cultures. These factors need to be carefully considered
when choosing the best approach to take in attempting to
identify the products of a cryptic biosynthetic gene cluster.
Doubtless further approaches will be added to this already
impressive array as research activity in this exciting new
field continues to increase.
Discovery of coelichelin by S. coelicolor genome
mining
In the course of a search of microbial genome sequences for
gene clusters encoding novel NRPS systems, a cluster of 11
genes, one of which encodes a protein that is similar to
several well-characterized NRPSs, was discovered in the
partially completed genome sequence of S. coelicolor M145
(Fig. 7; Challis & Ravel, 2000). This gene cluster had not
been reported to be involved in the biosynthesis of any
known secondary metabolites of S. coelicolor. Sequence
analysis of the NRPS-like protein encoded by the cchH gene
in this cluster suggested that it contains 10 catalytic
domains, organized into three functional modules (Fig. 7;
Challis & Ravel, 2000). The first two modules both contain
domains similar to known epimerization (E) domains in
other NRPSs, suggesting that these modules incorporate D-
amino acids into the product of CchH. Application of the
predictive, structure-based models that Jacques Ravel and I
developed as postdoctoral researchers in Craig Townsend’s
group (Challis et al., 2000) suggested that the A domains in
modules 1, 2 and 3 of CchH selected the amino acids L-N5-
formyl-N5-hydroxyornithine (L-fhOrn), L-threonine and L-
N5-hydroxyornithine (L-hOrn), respectively, and catalysed
their ATP-dependent transfer onto the adjacent peptidyl
carrier protein (PCP) domains in each module (Challis &
Ravel, 2000; Fig. 7). Thus we proposed that CchH catalysed
assembly of the novel tripeptide D-fhOrn-D-allo-Thr-L-
hOrn, which could be formed as one of two essentially
isomeric structures, depending on the regiospecificity of
the condensation (C) domain in module 3 of the NRPS
Fig. 6. The expression of pathway-specific activator/comparative
metabolic profiling approach to identifying the product(s) of cryptic
biosynthetic gene clusters. Placing a pathway-specific activator
gene under the control of an inducible promoter results in
activation of transcription of the normally silent biosynthetic gene
cluster.
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(Fig. 7; Challis & Ravel, 2000). At this time we also noted
one unusual feature of CchH, which was that unlike
virtually all other NRPS multienzymes, it lacked a
thioesterase (TE) domain for hydrolytic offloading of
the fully assembled peptide product from the PCP
domain in the last module of the synthetase (Challis &
Ravel, 2000).
Sequence analysis of the proteins encoded by other genes in
the 11-gene cch cluster supported the proposed structure of
the CchH product. For example, cchB encodes a protein
that could convert L-ornithine to its N5-hydroxy derivative
(L-hOrn) and cchA encodes a protein that could catalyse
N5-formylation of L-hOrn (Challis & Ravel, 2000). Thus,
plausible pathways for provision of the proposed non-
proteinogenic amino acid substrates of modules 1 and 3 of
the CchH NRPS could be envisioned.
Sequence analysis of the intergenic regions between the
cchA and cchB genes, and the cchH and cchI genes, showed
that they contained inverted repeat sequences similar to
known binding sites for ferrous iron-dependent repressor
(IdeR) proteins in Streptomyces pilosus (Fig. 7; Barona-
Go´mez et al., 2006; Gu¨nter et al., 1993). The ferrous
complexes of such repressor proteins bind to the inverted
repeats and prevent expression of the adjacent genes. When
ferrous iron becomes scarce inside the cell the apo-proteins
of the repressor are formed, which allows expression of the
adjacent genes. Thus this analysis indicated that the cch
gene cluster would only be expressed when iron is deficient,
suggesting appropriate culture conditions for production
of the metabolite ‘encoded’ by the cch gene cluster.
The proposed structures of the products of CchH suggested
a strategy for their selective detection in culture super-
natants of S. coelicolor. Both proposed structures contain
hydroxamic acid functional groups and it is well known
that the deprotonated forms of such functional groups can
complex ferric iron. Ferric tris-hydroxamate complexes
exhibit characteristic absorbance maxima at 435 nm and it
was envisaged that the proposed products of CchH could
make such complexes (2-ligand : 1-iron or 3-ligand : 2-iron
complexes). Thus, we envisaged that it should be possible
to detect the products of CchH by addition of ferric iron to
culture supernatants of S. coelicolor, followed by HPLC
analysis monitoring absorbance at 435 nm (Fig. 7).
In the event that multiple metabolites absorbing at 435 nm
were observed after addition of ferric iron to culture
supernatants of S. coelicolor grown under iron-deficient
conditions, we wanted to distinguish between those that
were products of the cch gene cluster and those that were
not. We therefore inactivated the cchH gene in S. coelicolor
by single-crossover integration of a pKC1132 derivative
containing an internal fragment of cchH (Lautru et al.,
2005). Growth of the resulting mutant and the wild-type
strain in a medium rendered iron deficient by treatment
with Chelex resin, followed by addition of ferric iron to the
culture supernatants and comparative metabolic profiling
using HPLC, identified a compound absorbing at 435 nm
that was absent in the mutant, but present in the wild-type
(Lautru et al., 2005). This ferric complex was purified and
the metal was removed (Lautru et al., 2005). The iron-free
Fig. 7. Organization of the cch gene cluster in S. coelicolor and
the NRPS encoded by the cchH gene. Vertical arrows indicate the
location of putative ferrous iron-dependent repressor (IdeR)
binding sites in two intergenic regions within the cluster. The
substrates predicted to be recognized by the A domain in each
module of the NRPS are shown attached to the adjacent PCP
domains (black circles). Two predicted possible structures of the
products of CchH, assuming collinearity between the order and
number of modules and the sequence of the peptide product, are
shown. These compounds were postulated to form complexes with
ferric iron that absorb light at 435 nm, because they contain
hydroxamic acid functional groups.
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compound was structurally characterized by high-
resolution and tandem ESI-MS (Lautru et al., 2005).
Extensive 1- and 2D NMR spectroscopy and molecular
modelling of the corresponding gallium complex was also
carried out (Lautru et al., 2005). The resulting structure of
the product of the cryptic cch gene cluster of S. coelicolor
was deduced to be the tetrapeptide D-fhOrn-D-allo-Thr-L-
hOrn-D-fhOrn (Fig. 8; Lautru et al., 2005). This novel
natural product was named coelichelin because it is a new
S. coelicolor iron chelator.
Investigations of coelichelin biosynthesis
The finding that the product of the cch cluster is a
tetrapeptide containing two residues of fhOrn, one residue
of Thr and one residue of hOrn, rather than one residue of
each of these amino acids, was quite a surprise. It suggested
that coelichelin may be the first example of a tetrapeptide
assembled by a trimodular NRPS. Several alternative
models for the assembly of coelichelin by the trimodular
NRPS CchH can be proposed. All involve the iterative use
of module 1 to incorporate two molecules of fhOrn into
coelichelin (Fig. 9). Furthermore, the direct linkage
between the fhOrn and hOrn residues in the experiment-
ally determined structure of coelichelin implies the direct
or indirect interaction of modules 1 and 3 of CchH during
the assembly process (i.e. formal ‘skipping’ of module 2).
The cchH gene is the only gene within the cch cluster that
encodes a protein with significant sequence similarity to an
NRPS. Nevertheless, it is possible that a gene outside the
cch cluster, located elsewhere on the chromosome of S.
coelicolor, could encode a fourth NRPS module that
participates in assembly of the coelichelin tetrapeptide
structure. To exclude this possibility we integrated a single
cosmid containing the entire cch gene cluster into the
chromosome of the coelichelin non-producer Streptomyces
fungicidicus (Lautru et al., 2005). The resulting strain
produced coelichelin under iron-deficient conditions,
providing strong evidence that CchH is the only NRPS
required for assembly of the tetrapeptide and that the cch
cluster contains all of the genes required for coelichelin
biosynthesis in streptomycetes (Lautru et al., 2005).
Further evidence for the conclusion that the cch gene
cluster is sufficient for coelichelin biosynthesis in strepto-
mycetes comes from the finding that an essentially identical
gene cluster in Streptomyces ambofaciens also directs
production of this tetrapeptide (Barona-Go´mez et al.,
2006).
As mentioned above, an unusual feature of the coelichelin
NRPS is that it lacks a C-terminal TE domain for
hydrolytic cleavage of the tetrapeptidyl thioester attached
to the PCP domain in module 3 of CchH. The cchJ gene
encodes an enzyme showing significant sequence similarity
to Fes, IroD and IroE, enzymes from enteric bacteria that
catalyse hydrolytic cleavage of the trilactone ring of ferric-
enterobactin and related molecules (Lautru et al., 2005; Lin
et al., 2005). A recent crystal structure of IroE shows that it
belongs to the a,b-hydrolase superfamily of enzymes and
contains an atypical Ser-His catalytic dyad at its active site
(Larsen et al., 2006). TE domains also belong to the a,b-
hydrolase superfamily and contain Ser-His-Asp catalytic
triads. Thus it occurred to us that CchJ could be acting as a
thioesterase that catalyses hydrolytic cleavage of the fully
assembled coelichelin tetrapeptidyl chain from the PCP
domain in module 3 of CchH. To test this hypothesis, we
replaced the cchJ gene on the chromosome of S. coelicolor
M145 with an oriT-aac(3)IV cassette, which confers
apramycin resistance, using PCR-targeting-based meth-
odology (Gust et al., 2003; Lautru et al., 2005). The
resulting mutant was unable to produce coelichelin under
iron-deficient growth conditions (Lautru et al., 2005).
Complementation by integration of a plasmid containing
the cchJ gene under the control of the constitutive ermE*
promoter into the chromosome of the mutant restored
coelichelin production under iron-deficient growth condi-
tions (S. Lautru & G. L. Challis, unpublished data). These
results show that CchJ is required for coelichelin
biosynthesis and are consistent with the hypothesis that it
acts as the terminal thioesterase in this process (Fig. 9).
The cchA and cchB genes encode enzymes hypothesized to be
capable of converting ornithine to the non-proteinogenic
amino acids hOrn and fhOrn that are incorporated into the
coelichelin structure (Fig. 10). To investigate this hypothesis,
we replaced the cchA gene in S. coelicolor M145 with an oriT-
aac(3)IV cassette using PCR-targeting methodology. The
resulting mutant was unable to produce coelichelin under
iron-deficient conditions. If the proposed function of CchA
as a formyl-tetrahydrofolate-dependent formyltransferase
capable of converting hOrn to fhOrn is correct, feeding of
chemically synthesized fhOrn to the cchA : : oriT-aac(3)IV
mutant of S. coelicolor should restore coelichelin production.
This indeed proved to be the case (D. Oves-Costales, C.
Corre & G. L. Challis, unpublished data), providing strong
evidence for the hypothesized function of CchA.
The majority of gene clusters containing an NRPS-
encoding gene also contain a gene encoding a small
Fig. 8. The experimentally elucidated structure of coelichelin, the
product of the S. coelicolor cch gene cluster.
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(,100 amino acid) MbtH-like protein of unknown
function. The cch gene cluster is no exception. The cchK
gene encodes an MbtH-like protein. Since no conclusive
studies examining the requirement for genes encoding
MbtH-like proteins in nonribosomal peptide biosynthesis
had been reported, we decided to investigate the require-
ment of cchK for coelichelin biosynthesis. Thus we deleted
cchK on the chromosome of S. coelicolor (Lautru et al.,
2007). The resulting mutant still produced coelichelin, but
at a lower level than the wild-type strain (Lautru et al.,
2007). It occurred to us that an orthologue of CchK
encoded by the cdaX (SCO3218) gene within the cda gene
cluster that directs calcium-dependent antibiotic (CDA)
biosynthesis in S. coelicolor might be partially complement-
ing the cchK deletion (Hojati et al., 2002). We therefore
replaced the cdaX gene in S. coelicolor with the oriT-
aac(3)IV cassette (Lautru et al., 2007). This resulted in a
strain that did not produce CDA on iron-replete medium,
but did produce the antibiotic when iron deficiency was
enforced by addition of 2,29-bipyridyl to the medium
(Lautru et al., 2007). These results indicated that CchK
could complement the cdaX deletion, suggesting that the
CchK and CdaX MbtH-like proteins mediate cross-talk
between the coelichelin and CDA biosynthetic pathways.
To further investigate this hypothesis we constructed a
cchK/cdaX double mutant of S. coelicolor (Lautru et al.,
2007). The production of both coelichelin and CDA was
abolished in this mutant, showing that MbtH-like proteins
are required for the biosynthesis of both these nonriboso-
mal peptides in S. coelicolor (Lautru et al., 2007).
Expression of either cdaX or cchK in the double mutant
restored production of both CDA and coelichelin under
appropriate growth conditions, showing that it is indeed
the MbtH-like proteins encoded by these genes that
mediate cross-talk between the two biosynthetic pathways
(Lautru et al., 2007).
While these studies firmly established the requirement for
MbtH-like proteins in nonribosomal peptide biosynthesis
in S. coelicolor, they did not shed light on the possible role
of these proteins. One possibility is that CchK and CdaX
are transcriptional regulators of the coelichelin and CDA
biosynthetic genes. To investigate this hypothesis, RT-PCR
analyses of transcript levels for biosynthetic genes in the
cda and cch gene clusters were carried out in wild-type S.
coelicolor and the cchK/cdaX mutant (Lautru et al., 2007).
No significant differences were observed, suggesting that
MbtH-like proteins may not regulate transcription of
Fig. 9. Proposed assembly of a tetrapeptidyl
thioester by CchH, involving iterative use of
module 1 and formal skipping of module 2 in
the second iteration. CchJ is proposed to
catalyse hydrolytic cleavage of the assembled
tetrapeptide from the PCP domain in module 3
of CchH.
Fig. 10. Proposed roles of CchA and CchB in the biosynthesis of
non-proteinogenic amino acid precursors of coelichelin from
ornithine. fTHF, formyltetrahydrofolate.
Fleming Prize Lecture 2007
http://mic.sgmjournals.org 1561
nonribosomal peptide biosynthetic genes (Lautru et al.,
2007). The X-ray crystal structure of an MbtH-like protein
encoded by a gene within the pyoverdine biosynthetic gene
cluster of Pseudomonas aeruginosa has recently been
reported (Drake et al., 2007; Fig. 11). However, this
structure does not suggest possible functions for these
proteins in nonribosomal peptide biosynthesis. One
possibility is that MbtH-like proteins could interact
directly with NRPSs in some way to increase the efficiency
of peptide biosynthesis. Further experiments will be
required to test this hypothesis and define a role for these
essential proteins in nonribosomal peptide assembly.
The biological function of coelichelin
NMR studies of the Ga-coelichelin complex suggest that this
novel S. coelicolor natural product may be capable of making
a strong tris-hydroxamate complex with ferric iron. Indeed
the formation of a 1 : 1 ferric-coelichelin tris-hydroxamate
complex (ferricoelichelin) is supported by ESI-MS analyses
and UV-visible spectroscopy, which shows a broad absor-
bance with a maximum at 435 nm (accounting for the red
colour of the complex) that is characteristic of ferric tris-
hydroxamate complexes (Barona-Go´mez et al., 2006;
Fig. 12). Several natural products containing hydroxamic
acid functional groups are known to play a role in microbial
iron uptake. Although iron is the fourth most abundant
element in the Earth’s crust, in its ferric form it exists
predominantly as highly insoluble oxide/hydroxide poly-
meric complexes from which saprophytic micro-organisms
cannot directly remove the iron. Similarly in mammals free
iron levels are very low because storage and transport
proteins such as transferrin and lactoferrin bind ferric iron
with high affinity, thus preventing pathogenic microbes
from directly acquiring ferric iron from their hosts. Iron is
an essential element for growth and proliferation of nearly
all micro-organisms. As a consequence, many biosynthesize
and excrete high-affinity ferric iron chelators called side-
rophores, which scavenge iron from deposits in the
environment or their hosts (Miethke & Marahiel, 2007).
Active transport systems translocate the iron-siderophore
complexes into microbial cells and once they are inter-
nalized, the iron is removed by reductive and/or hydrolytic
processes (Miethke & Marahiel, 2007).
Sequence analyses of the proteins encoded by the cchCDEF
genes indicated that they are similar to lipoprotein receptor,
permease and ATPase components of known ferric-
siderophore transport systems in other bacteria (Miethke
& Marahiel, 2007; Fig. 13). Together with the experimentally
proven affinity of coelichelin for ferric iron and the sequence
analyses of intergenic regions in the cch cluster suggesting
that its expression is controlled by intracellular iron levels
(Barona-Go´mez et al., 2006), this observation suggested that
coelichelin plays a role in iron uptake by S. coelicolor. In
other work we had identified the des gene cluster that directs
the production of known tris-hydroxamic acid-containing
desferrioxamines of S. coelicolor (Barona-Go´mez et al.,
2004). Ferrioxamine complexes are known to be utilized as
iron sources by Streptomyces pilosus (Muller & Raymond,
1984), thus it seemed likely that the desferrioxamine
products of the des cluster as well as coelichelin could play
a role in S. coelicolor iron acquisition.
To test these hypotheses we created independent mutants
of S. coelicolor lacking the NRPS-encoding cchH gene and
the desD gene (Barona-Go´mez et al., 2004, 2006), which
encodes an enzyme that catalyses the key step in
Fig. 11. Structure of the MbtH-like protein encoded by a gene
within the pyoverdine biosynthetic gene cluster of P. aeruginosa.
The side chains of three Trp residues that are universally
conserved in MbtH-like proteins are highlighted in space-filling
representation.
Fig. 12. Structure of the ferricoelichelin complex.
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desferrioxamine biosynthesis (Kadi et al., 2007). The cchH
mutant was incapable of producing coelichelin, but still
produced desferrioxamines (Barona-Go´mez et al., 2006).
Conversely the desD mutant did not produce desferriox-
amines (Barona-Go´mez et al., 2004), but still made
coelichelin (Barona-Go´mez et al., 2006). We also con-
structed a mutant lacking both the cchH and desD genes,
which did not produce coelichelin or desferrioxamines
(Barona-Go´mez et al., 2006). The ability of these mutants
to grow on a colloidal silica medium was examined. While
both the single mutants could grow on this medium
provided ferric iron was added, the double mutant could
not, even in the presence of high concentrations of ferric
iron (Barona-Go´mez et al., 2006). Addition of purified
ferrioxamines or ferricoelichelin to the double mutant
restored growth (Barona-Go´mez et al., 2006). These data
strongly suggest that both desferrioxamines and coelichelin
function as siderophores that mediate iron uptake in S.
coelicolor.
Discovery of new and known germicidins by S.
coelicolor genome mining
Type III PKSs catalyse the iterative decarboxylation and
concomitant condensation of malonyl-CoA building
blocks to form a poly-b-ketomethylene intermediate of
defined chain length that typically undergoes PKS-
catalysed cyclization and dehydration reactions to yield
an aromatic product (Austin & Noel, 2003). Important
bacterial examples include DpgA from Amycolatopsis
orientalis, which with the assistance of DpgB and DpgC
catalyses the assembly of 3,5-dihydroxyphenylacetyl-CoA
(a precursor of the non-proteinogenic amino acid 3,5-
dihydroxyphenylglycine that is incorporated into the
antibiotic vancomycin) from four molecules of malonyl-
CoA (Chen et al., 2001; Li et al., 2001; Pfeifer et al., 2001;
Fig. 14), and RppA from Streptomyces griseus, which
catalyses the assembly of 1,3,6,8-tetrahydroxynaphthalene
from five molecules of malonyl-CoA (Funa et al., 1999;
Fig. 15). The molecular mechanisms by which type III
PKSs control chain length and cyclization regiochemistry
are still not well understood. Thus, it is difficult to predict
the structures of the likely products of putative novel type
III PKSs uncovered by genome sequencing.
Analysis of the S. coelicolor complete genome sequence
identified three genes encoding proteins with significant
sequence similarity to known type III PKSs (Bentley et al.,
2002). One of these proteins showed a high degree of
sequence similarity to RppA and, not surprisingly, was
subsequently shown to catalyse assembly of 1,3,6,8-
Fig. 13. Proposed function of CchF (lipoprotein receptor), CchC/
CchD (membrane-spanning permeases) and CchE (ATPase) as
components of an ABC transporter system that mediates the
selective uptake of ferricoelichelin in S. coelicolor. Reductive
release of iron from ferricoelichelin would yield ferrous iron for
utilization in biochemical processes that are vital for the survival of
the cell.
Fig. 14. Reactions catalysed by the type III
PKS DpgA in the biosynthesis of 3,5-dihy-
droxyphenylacetyl-CoA. DpgB and DpgC
assist in this process.
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tetrahydroxynaphthalene (Izumikawa et al., 2003). To
attempt to identify the product(s) of one of the two
remaining cryptic putative type III PKS enzymes we
replaced the gcs (SCO7221) gene on the chromosome of
S. coelicolor with a cassette conferring apramycin resistance
using PCR targeting (Song et al., 2006). Comparison of the
metabolites in the organic extracts from culture super-
natants of wild-type S. coelicolor and the gcs mutant using
LC-MS identified five compounds that were present in the
wild-type, but lacking in the mutant (Song et al., 2006).
The major component of this complex was purified from
the extract and analysed by ESI-TOF-MS, ESI-MS/MS, and
1- and 2D NMR spectroscopy (Song et al., 2006). From
these analyses the compound was deduced to be germicidin
A, a known inhibitor of streptomycete spore germination,
isolated along with its desmethyl analogue germicidin B
from Streptomyces viridochromogenes (Petersen et al., 1993;
Fig. 16). Feeding of stable isotope-labelled precursors and
LC-MS/MS analyses together with NMR and MS analyses
of another purified component of the mixture established
the structures of the other five members of the complex as
the other known compound germicidin B and three new
compounds, which were named isogermicidin A, isoger-
micidin B and germicidin C (Song et al., 2006; Fig. 16).
New type III PKS enzymology in germicidin
biosynthesis
The identification of germicidins as the products of a type
III PKS was quite unexpected. The feeding studies with
stable isotope-labelled precursors indicated that germicidin
A is assembled from one molecule of 2-methylbutyryl-CoA,
one molecule of malonyl-CoA and one molecule of
ethylmalonyl-CoA. (Fig. 17). There appears to be no
precedent for the utilization of ethylmalonyl-CoA as an
extender unit by type III PKSs, although it has been
proposed to be used in this capacity by type I modular
PKSs (Erb et al., 2007). To establish whether the gcs gene is
sufficient for germicidin production in streptomycetes, we
integrated a plasmid containing gcs under the control of
the constitutive ermE* promoter into the chromosome of
Streptomyces venezuelae, which is known not to contain a
gcs orthologue and does not produce germicidins (Song
et al., 2006). The resulting strain produced all five
germicidins, showing that gcs is indeed the only gene
required for germicidin biosynthesis in streptomycetes
(Song et al., 2006).
These results suggested two alternative possible roles for
the type III PKS encoded by gcs in germicidin biosynthesis.
In the first role, the PKS catalyses condensation of an acyl-
CoA starter unit (preferentially 2-methylbutyryl-CoA or
isobutyryl-CoA) with a molecule of malonyl-CoA, followed
by a molecule of ethylmalonyl- or methylmalonyl-CoA to
form a triketide, which undergoes cyclization with loss of
CoASH to yield the corresponding pyrone (Fig. 18). In the
second role, the PKS catalyses elongation of the b-ketoacyl-
ACP products of the FabH fatty acid biosynthetic enzyme
with a molecule of ethylmalonyl- or methylmalonyl-CoA,
followed by cyclization of the resulting triketide to form
Fig. 15. Reactions catalysed by the type III
PKS RppA in the assembly of 1,3,6,8-tetra-
hydroxynaphthalene in S. griseus and S.
coelicolor.
Fig. 16. Structures of germicidins isolated
from S. coelicolor by genome mining.
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the pyrone (Fig. 19). Both of these hypothetical roles
involve novel type III PKS enzymology. In the first potential
role, the PKS would catalyse successive rounds of chain
extension with different extender units, which appears to be
without precedent for iterative PKSs. In the second
potential role, the PKS would catalyse transacylation of a
b-ketoacyl thioester (formed by the primary metabolic fatty
acid biosynthesis enzyme FabH) from an ACP to the active-
site cysteine residue of the PKS and elongation with
ethylmalonyl-CoA (or methylmalonyl-CoA).
To discriminate between the two possible roles of the type
III PKS, we analysed germicidin production in a mutant of
S. coelicolor in which the gene encoding the endogenous
FabH protein (which preferentially elongates branched-
chain acyl-CoA thioesters, especially 2-methylbutyryl-CoA
and 3-methylbutyryl-CoA, with malonyl-CoA) was
replaced with the gene encoding the FabH enzyme from
Escherichia coli (which preferentially elongates acetyl-CoA
with malonyl-CoA) (Li et al., 2005). In wild-type S.
coelicolor fatty acids are derived predominantly from the
branched-chain 2-methylbutyryl-CoA, 3-methylbutyryl-
CoA and isobutyryl-CoA starter units (74 %, the remaining
26 % are derived from straight-chain starter units; Fig. 20).
On the other hand, in the S. coelicolor mutant in which the
endogenous fabH gene has been replaced with its
counterpart from E. coli, 88 % of the fatty acids are derived
from straight-chain starter units (acetyl-CoA, propionyl-
CoA and possibly butyryl-CoA), while the remaining 12 %
derive from an isobutyryl-CoA starter unit (Li et al., 2005;
Fig. 20). In the same mutant, only germicidin B and
isogermicidin B, which are derived from isobutyryl-CoA
and butyryl-CoA starter units, respectively, are produced
(Song et al., 2006; Fig. 20). This result implicates FabH in
germicidin assembly and strongly suggests that the
germicidin type III PKS elongates ACP-bound b-ketoacyl
thioester intermediates in fatty acid biosynthesis with
ethylmalonyl-CoA and catalyses cyclization of the resulting
triketides to form the corresponding pyrones. Sherman and
coworkers have recently reported biochemical evidence that
supports our hypothesis that the germicidin type III PKS
utilizes an acyl-ACP starter unit (Gru¨schow et al., 2007)
Fig. 17. Incorporation pattern of stable-iso-
tope-labelled precursors into germicidin A and
proposed direct acyl-CoA precursors of this
antibiotic.
Fig. 18. Possible role for the type III PKS Gcs
in germicidin A assembly. This role is incon-
sistent with the experimental data.
Fleming Prize Lecture 2007
http://mic.sgmjournals.org 1565
Contemporaneous with our studies on germicidin biosyn-
thesis, Joseph Noel and co-workers discovered a unique
type I fatty acid synthase (FAS)-type III PKS hybrid that is
involved in differentiation-inducing factor biosynthesis in
Dictyostelium discoideum (Austin et al., 2006). The
arrangement of catalytic domains in this hybrid multi-
enzyme suggests that the type III PKS-like domain extends
an acyl-ACP thioester, assembled by the type I FAS
domains, with three malonyl-CoA units and catalyses
subsequent cyclization and aromatization reactions, pro-
viding a second potential example of a type III PKS that
utilizes an acyl-ACP starter unit assembled by a FAS. Very
recently, Horinouchi and coworkers have demonstrated
biochemically that an acyl-ACP thioester assembled on a
type I FAS is elongated with three molecules of malonyl-
CoA, and subsequently cyclized and aromatized, by a type
III PKS in the biosynthesis of phenolic lipids in Azotobacter
vinelandii (Miyanaga et al., 2008). Thus the emerging
view is that utilization of FAS-assembled acyl-ACP
starter units by type III PKSs may be a relatively com-
mon phenomenon. On the other hand, utilization of
ethylmalonyl-CoA as an extender unit by a type III PKS
Fig. 19. Alternative possible role for the type
III PKS Gcs in germicidin A assembly and
possible roles of the FabH enzyme and ACP
involved in fatty acid biosynthesis in S.
coelicolor. These roles are consistent with
the available experimental data.
Fig. 20. Main fatty acids produced by wild-
type S. coelicolor and an S. coelicolor mutant
in which the fabH gene has been replaced by
its functional homologue from E. coli. The
structures of the germicidins produced by the
mutant are also shown. Putative starter units
for the fatty acids and germicidins produced
are highlighted with bold bonds.
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thus far seems to remain a unique property of germicidin
synthase.
Conclusions
Mining of the S. coelicolor genome has yielded one of the
first examples of a novel natural product to be discovered
by a genomics-guided approach and a rich vein of new
biosynthetic chemistry. Our efforts to mine the genome of
S. coelicolor and other streptomycetes are ongoing and have
resulted in the discovery of further new natural products
with fascinating biological activities and novel mechanisms
of biosynthetic assembly. The details of these discoveries
will be disclosed in the near future.
Over the past four years, the field of genome mining for
new natural products has exploded. There have been
numerous reports of the discovery of novel natural
products from sequenced microbes by genomics-guided
approaches, hinting that we may be on the verge of a
second golden age of new bioactive natural product
discovery. Experimental techniques for discovery of the
products of cryptic biosynthetic gene clusters continue to
be developed and refined. One important challenge that
lies ahead is the development of general methods for
activating the expression of silent cryptic biosynthetic gene
clusters.
Much new biosynthetic chemistry has been discovered over
the past 20 years by sequencing-based approaches. Progress
in this area has accelerated recently thanks to the avalanche
of genomic information since the turn of the century.
Doubtless, much new, exciting and intriguing biosynthetic
chemistry remains to be discovered in the future through
the continued exploitation of information from genome
sequencing projects.
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